Search Results: PARP inhibitors

• For Supporters

Catch up on Behind the Science 2021 – From funding stream to blood stream: Is drug development moving fast enough?

This year’s event took place virtually on Wednesday 12 May. Watch or listen back now. This year’s event took place virtually on Wednesday 12 May. Watch or listen back now.

18 May 2021

• Charity News

A tribute to Professor Gordon McVie

Almost 20 years since Cancer Research UK was founded, not many who worked with McVie remain, but staff know him as the man who gave the charity its beginning. Almost 20 years since Cancer Research UK was founded, not many who worked with McVie remain, but staff know him as the man who gave the charity its beginning.

18 February 2021

• Health & Medicine

NICE approves new maintenance treatment for ovarian cancer

A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer. A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.

19 January 2021

• Science & Technology
• Health & Medicine

Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off. 25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

14 January 2021

• Charity News

Cancer Research UK forced to cut research funding due to COVID-19

Due to the effects of COVID-19, Cancer Research UK has had to cut its research funding by £45 million. Due to the effects of COVID-19, Cancer Research UK has had to cut its research funding by £45 million.

8 December 2020

• Health & Medicine

Breast and ovarian cancer drug effective in advanced prostate cancer

A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer. A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer.

1 May 2020

• Health & Medicine

Coronavirus and cancer – latest updates

We're pulling together the latest government and NHS health updates concerning coronavirus (COVID-19) and cancer. We're pulling together the latest government and NHS health updates concerning coronavirus (COVID-19) and cancer.

19 March 2020

• Health & Medicine

Targeted drug trial points to potential ‘new age’ for pancreatic cancer treatment

A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy. A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.

2 June 2019

• Science & Technology

International Women’s Day: a Wikipedia edit-a-thon for women in cancer research 

Less than 1 in 5 Wikipedia biographies are about women. We wanted to change that. Less than 1 in 5 Wikipedia biographies are about women. We wanted to change that.

8 March 2019

• For Researchers

Celebrating a lifetime in cancer biology, an early diagnosis champion, and our leaders of tomorrow: the 2018 CRUK Research Prizes

We've awarded our annual research prizes at the NCRI Conference in Glasgow. Find out who won our Future Leaders, Jane Wardle, and Lifetime Achievement prizes. We've awarded our annual research prizes at the NCRI Conference in Glasgow. Find out who won our Future Leaders, Jane Wardle, and Lifetime Achievement prizes.

19 December 2018

• Health & Medicine

Targeted drug could slow progression of ovarian cancer in women with faulty BRCA gene

A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research. A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research.

24 October 2018